Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia

International Journal of Cardiology

Volumn 93, Issue 2-3, 2004, Pages 281-284

  Tambara, Keiichi ^a   Fujita, Masatoshi ^a   Miyamoto, Shoichi ^a   Doi, Kazuhiko ^a   Nishimura, Kazunobu ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Heart type cytoplasmic fatty acid binding protein; Myocardial ischemia; Pericardial fluid; Unstable angina

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; HEART TYPE CYTOPLASMIC FATTY ACID BINDING PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE MARKER; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ST SEGMENT; STERNOTOMY; SYMPTOM;

EID: 1242294568     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(03)00219-5     Document Type: Article

References (10)

1. Glatz J.F.C., van der Vusse G.J., Simoons M.L., Kragten J.A., van Dieijen-Visser M.P., Hermens W.T. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta. 272:1998;87-92.
2. de Groot M.J.M., Wodzig K.W.H., Simoons M.L., Glatz J.F.C., Hermens W.T. Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates. Cardiovasc Res. 44:1999;315-324.
3. Fujita M., Ikemoto M., Kishishita M., et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation. 94:1996;610-613.
4. Tanaka T., Hasegawa K., Fujita M., et al. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. J Am Coll Cardiol. 31:1998;399-403.
5. Tambara K., Fujita M., Nagaya N., et al. Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodeling. Heart. 87:2002;242-246.
6. Page E., Upshaw-Earley J., Goings G. Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules: stretch-dependent effects. Circ Res. 71:1992;159-173.
7. Ohkaru Y., Asayama K., Ishii H. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods. 178:1995;99-111.
8. Jennings R.B., Reimer K.A., Steenbergen C. Myocardial ischemia revisited: the osmolar load, membrane damage, and reperfusion. J Mol Cell Cardiol. 18:1986;769-780.
9. Chu W.W., Dieter R.S., Stone C.K. A review of clinically relevant cardiac biochemical markers. Wisc. Med J. 101:2002;40-48.
10. Jesse R.L., Kukreja R. Rationale for the early clinical application of markers of ischemia in patients with suspected acute coronary syndromes. Cardiovasc Toxicol. 1:2001;125-133.